Description
DR Lalchandani Labs Limited has announced a 1:1 rights issue of equity shares at par value of Rs. 10 per share, with record date on January 27, 2026.
Summary
DR Lalchandani Labs Limited (Scrip Code: 541299) has fixed the record date for a rights issue of equity shares. The company will issue 1 equity share of Rs. 10 each for every 1 equity share held by shareholders as on the record date. Trading will be on ex-rights basis from January 27, 2026.
Key Points
- Rights ratio: 1:1 (one new share for every one share held)
- Face value: Rs. 10 per share
- Issue price: Rs. 10 per share (at par)
- Entire issue price payable on application
- Scrip code: 541299
- Settlement: DR-806/2025-2026
- Segment: Dematerialised Securities - Rolling Settlement
Corporate Action Details
This is a rights issue where existing shareholders will be entitled to subscribe to one new equity share for every one share held on the record date. The shares are being offered at par value with no premium.
Compliance Requirements
- Trading members must execute transactions on ex-rights basis from the specified date
- All trades from January 27, 2026 onwards will be without rights entitlement
- Trading members are required to note and implement this change
Important Dates
- Record Date: January 27, 2026
- Ex-Rights Date: January 27, 2026
- Notice Date: January 21, 2026
- Settlement Number: DR-806/2025-2026
Impact Assessment
Shareholder Impact: Existing shareholders will have the opportunity to maintain their proportional ownership by subscribing to the rights issue. The 1:1 ratio is dilutive for non-participating shareholders.
Trading Impact: Shares will trade ex-rights from January 27, 2026, which may result in price adjustment to reflect the rights entitlement separation.
Payment Terms: Full payment of Rs. 10 per share is required on application, with no installment option available.
Impact Justification
Standard rights issue announcement affecting existing shareholders with 1:1 entitlement ratio at par value